1、1734MO - Hypoxic bladder cancers have a poorer outcome following hypofractionated vs conventionally fractionated radiotherapy in the BC2001 and BCON randomised trials 责任编辑 | 猫爷 版权声明:本平台旨在帮助医疗卫生专业人士更...
BC2001 is the largest muscle invasive bladder cancer (MIBC) radiotherapy trial undertaken to date and showed that addition of chemotherapy to radiotherapy achieves local control of invasive disease in over 80% of patients. Secondary time to event outcomes included non-invasive loco-regional recurrence...
藻类(Bladderwrack)OAS AEB2164 (C:33.67%,H:4.97%,N;1.25%,S:2.289%),30g 白桦叶 OAS AEB2166 (C: 48.09, H: 6.55%, N: 2.12%, S: 0.172%),30g 椰壳OAS AEB2168 (C: 49.04%, H: 6.01%, N: 0.09%),30g 橄榄油同位素工作标准品 (C13) AEB2172 5G 尿素同位素工作标准品 AEB2174 (...
Bladder drainage (BD... HW Sollinger,JS Odorico,SJ Knechtle,... - 《Annals of Surgery》 被引量: 822发表: 1998年 Metabolic consequences of pancreatic systemic or portal venous drainage in simultaneous pancreas-kidney transplant recipients Aims The aim was to investigate pancreatic B-cell function...
7102 Updated results of the BC2001 phase III randomized trial of standard vs reduced high dose volume radiotherapy for muscle invasive bladder cancer (ISCRTN:68324339): tumour control, toxicity and quality of liferenal failureelectron microscopyThe ultrastructure of multinucleated giant myeloma cells ...
Co-primary endpoints were invasive locoregional control (non-inferiority margin hazard ratio [HR]=1·25); and late bladder or rectum toxicity, assessed with the Late Effects Normal Tissue Task Force-Subjective, Objective, Management, Analytic tool (non-inferiority margin for absolute risk difference ...
7102 Updated results of the BC2001 phase III randomized trial of standard vs reduced high dose volume radiotherapy for muscle invasive bladder cancer (ISCRTN:68324339): tumour control, toxicity and quality of lifeHuddartR.JamesN. D.Adab
Effect of Reducing Radiotherapy Volume on Bladder Toxicity: First Report of the BC2001 Trial; A Multicenter Phase III Randomized Trial of Standard versus Reduced Volume Radiotherapy Trial Iscrtn No. 68324339, Eudract No. 2004-000164-26doi:10.1016/j.ijrobp.2008.06.1039R.A....
First Toxicity Report of the BC2001 Trial: A Multicentre Phase III Randomised Trial of Radiotherapy with and without Synchronous Chemotherapy in Muscle Invasive Bladder Cancer ISCRTN No. 68324339, EUDRACT No. 2004-000164-26doi:10.1016/j.ijrobp.2008.06.783N.D....
Radiotherapy with or Without Chemotherapy in Muscle-Invasive Bladder Cancer: James ND, for the BC2001 Investigators (Univ of Birmingham, UK; etal) N Engl J Med 366:1477-1488, 2012§doi:10.1016/j.yuro.2012.07.033KibelA.S.ELSEVIERYearbook of Urology...